Your Annual HIV Update


AIDS is no longer the death sentence it once was when it emerged in the United States more than 30 years ago. A steady stream of novel agents and new combinations of medications continues to expand treatment options and improve patient prognosis. Get the latest update on HIV/AIDS prevention and treatment, including clinical practice recommendations, newly approved products and investigational therapies, and evidence-based approaches to care from noteworthy clinical trials.

This session will be audio-recorded and offered as part of the Home-Study on Demand, included with Premium Registration or available for purchase on-site at the Education Booth.

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Identify important changes in recently updated guidelines that have the potential to influence the management of HIV/AIDS.
  2. Summarize clinically important drug updates, adverse effects, and drug-drug interactions associated with new drug classes used in the management of HIV/AIDS and common comorbidities.
  3. Outline strategies for improving patient adherence to HIV/AIDS drug therapy.


This activity is supported by an independent educational grant from Merck & Co., Inc.

Betty Dong, PharmD
Professor of Clinical Pharmacy and Medicine
University of California School of Pharmacy
Learning Level: Level 2
Pathway: Home-Study on Demand
Track: Specialty Pharmacy, Clinical Patient Care and Services
Session Time Slot(s): 
Monday, March 19
10:00 AM - 12:00 PM
Music City Center - Room 101C-D
ACPE Pharmacist: 0202-0000-18-063-L02-P
CEUs Pharmacist: 0.2
Activity Type: